Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Neoadjuvant Strategies for Rectal Cancer

February 14th 2019

Adjuvant Therapy for High-Risk Colon Cancer

February 14th 2019

Patient Stratification in Colon Cancer: ctDNA

February 14th 2019

Adjuvant Therapy for Early-Stage Colon Cancer

February 14th 2019

Relapsed/Refractory mCRC: Treatment Dosing Strategies

February 14th 2019

Treatment Recommendations for Relapsed/Refractory mCRC

February 14th 2019

Rationale for I-O in mCRC

February 14th 2019

Management of NTRK Fusions in CRC

February 14th 2019

Triplet Regimens for BRAF V600E-Positive mCRC

February 14th 2019

Sequencing Therapy in CRC: REVERCE Trial

February 14th 2019

Sequencing Therapy in CRC: E7208 Trial

February 14th 2019

Maintenance Strategies for Patients With mCRC

February 14th 2019

EGFR Therapy in Left-Sided CRC

February 14th 2019

Recommendations for Molecular Testing in mCRC

February 14th 2019

EGFR Therapy for Right-Sided CRC

February 14th 2019

Dr. Eng on the Treatment Landscape in Metastatic Colorectal Cancer

February 13th 2019

Cathy Eng, MD, professor of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center, discusses the treatment landscape in newly diagnosed metastatic colorectal cancer (mCRC).

Older Patients With Gastric Cancer May Derive Greater Benefit From Andecaliximab

February 9th 2019

Manish A. Shah, MD, discusses the results of the GAMMA-1 trial and challenges that remain for patients with gastric cancer.

Dr. Lee on Differences Between HIPEC and PIPAC in mCRC

February 9th 2019

Byrne Lee, MD, chief, Upper GI and Mixed Tumor Surgery Service, associate professor of surgical oncology, City of Hope, discusses the differences between HIPEC and PIPAC in the treatment of patients with metastatic colorectal cancer.

Microbial Metabolomics: A Search for the Missing Link to Cancer

February 8th 2019

Thanks to technological advances, the past several decades have witnessed a blossoming appreciation of the varied composition of these microbial communities, their complex and dynamic relationship with the host, and the way they affect health and disease.

Surgeon Highlights Regional Therapy Approaches for mCRC

February 8th 2019

Byrne Lee, MD, discusses regional treatment strategies for patients with metastatic colorectal cancer.